Energesis Receives Additional Phase II SBIR Award to Advance Brown Fat-Based Therapy
July, 2015 - Energesis has been awarded a second phase II SBIR contract from the Department of Defense to continue development of its brown fat targeted therapy for diabetes and obesity.
Energesis and LabCentral Startups Featured in Science Magazine
June, 2015 - Energesis and several LabCentral tenant companies were featured in the recent special issue in Science on entrepreneurship in the life sciences.
Science 12 June 2015: Got a Startup? Rent a Bench
Massachusetts Life Sciences Center Grants Energesis a Milestone Achievement Program (MAP) Award
May, 2015 - Energesis was selected as one of the winners of the MLSC's new MAP grant awards. The company will receive $200,000 in funding as one of the 12 awardees. MLSC press release.
Energesis Establishes Research Collaboration with Johnson & Johnson Innovation
June, 2014 - Janssen Pharmaceuticals, Inc. and Johnson & Johnson Innovation have established a collaboration with Energesis, aimed at identifying biological compounds that stimulate the formation of new brown fat for use in treating metabolic diseases. "J&J Innovation shows off its new summer lineup of biotech deals", Fierce Biotech.
Energesis Awarded Phase I SBIR Grant to Investigate Molecular Mechanisms for Creating New Brown Fat
May, 2014 - Energesis has received a Small Business Innovation Research (SBIR) grant from the National Institutes of Health to identify molecular targets capable of recruiting new brown adipocytes. This work is being supported by the National Institute for Diabetes and Digestive and Kidney Disease (NIDDK).
Energesis Awarded Phase II Grant to Further Brown Fat-Based Therpaeutics Development
June, 2012 - Energesis has been competitively selected for a Phase II Department of Defense Small Business Technology Transfer (STTR) award to continue its work on brown fat-targeted therapeutics. This work will be conducted with collaborators at Boston University and the Joslin Diabetes Center.
Energesis Awarded Phase I SBIR Grant to Investigate Approved Drugs for Creating New Brown Fat
March, 2012 - Energesis has received a Small Business Innovation Research (SBIR) grant from the National Institutes of Health to investigate the use of existing drugs to create new brown fat in patients and identify safe molecular mechanisms of action for expanding brown fat. This work is being supported by the National Institute for Diabetes and Digestive and Kidney Disease (NIDDK).
Energesis Pharmaceuticals Awarded STTR Grant to Develop Brown Fat-Based Therapeutics
June, 2011 - Energesis has been awarded a U.S. Department of Defense Small Business Technology Transfer (STTR) award to develop a new generation of brown fat-targeted therapeutics. The work will be conducted in collaboration with Boston University.
Energesis Pharmaceuticals is Winner of 2010 MassChallenge Global Start-up Competition
October, 2010 - Energesis Pharmaceuticals was the top life sciences winner of the 2010 MassChallenge Global Start-up Competition (www.masschallenge.org). The competition is the world's largest start-up contest, and this year's competition attracted 446 applications from 26 countries. The 111 highest-potential start-ups were invited to participate in a 3-month accelerator program providing intensive mentoring and access to free resources including office space, legal support and targeted introductions to customers and funding sources. Expert judges reviewed each start-up following the accelerator to identify the winners.
Energesis Pharmaceuticals Wins Therapeutic Discovery Tax Credit Grant
November, 2010 - Energesis Pharmaceuticals has been awarded a grant of $244,479.24 as part of the Therapeutic Discovery Tax Credit program established within the federal health reform law approved in March 2010.
Energesis Program Addressing Critical Military Need - Retired Military Leaders Fret Kids Will Be "Too Fat to Fight", CNBC, May, 17, 2014
Obesity Therapeutics Revisited, Biopharmconsortium, May 23, 2012
Treating Fat with Fat, The Scientist, May 2012
Entrepreneurs and Venture Capitalists – Piercing the "Pall of Gloom" Over Obesity Drugs, Biopharmconsortium, November 17, 2010
A Proton-Transporting Protein As An Obesity Drug Target, Chemical & Engineering News, November 3, 2010
Energesis Pharmaceuticals, Co-Founded by Sirtris Vet, Seeks to Tap Power of "Good Fat" in Fighting Obesity and Diabetes, Xconomy, November 3, 2010